{"slug":"bakerbros","name":"Baker Bros. Advisors","style":"sector_healthcare","grade":"A","book":[{"ticker":"INCY","issuer":"Incyte Corporation","shares":30744412.0,"value_usd":2893664057.0,"pct_book":16.62,"position_rank":1,"tilt_pp":15.384,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[{"key":"us_sector_health","name":"Health Care (Equal-Weight)","name_zh":"\u533b\u7597\u4fdd\u5065\uff08\u7b49\u6743\uff09"}],"since_excess":0.1864,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":70.0,"tier":"high","components":{"pct_book":{"value":1.0,"points":35.0},"rank_top10":{"value":1,"points":15.0},"tilt":{"value":15.384,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ONC","issuer":"BeOne Medicines Ltd.","shares":8799053.0,"value_usd":2613054769.0,"pct_book":15.0,"position_rank":2,"tilt_pp":13.773,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":69.6,"tier":"moderate","components":{"pct_book":{"value":0.988,"points":34.56},"rank_top10":{"value":2,"points":15.0},"tilt":{"value":13.773,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"INSM","issuer":"Insmed Incorporated","shares":7421111.0,"value_usd":1213500071.0,"pct_book":6.97,"position_rank":3,"tilt_pp":5.737,"action":"add","shares_change_pct":12.6,"add_streak_q":1,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":74.1,"tier":"high","components":{"pct_book":{"value":0.975,"points":34.12},"rank_top10":{"value":3,"points":15.0},"tilt":{"value":5.737,"points":10.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"MDGL","issuer":"Madrigal Pharmaceuticals, Inc.","shares":2141701.0,"value_usd":1121116222.0,"pct_book":6.44,"position_rank":4,"tilt_pp":5.206,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":68.7,"tier":"moderate","components":{"pct_book":{"value":0.963,"points":33.69},"rank_top10":{"value":4,"points":15.0},"tilt":{"value":5.206,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ACAD","issuer":"ACADIA Pharmaceuticals Inc.","shares":42896690.0,"value_usd":954880319.0,"pct_book":5.48,"position_rank":5,"tilt_pp":4.252,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Health Care","themes":[],"since_excess":0.1901,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":68.2,"tier":"moderate","components":{"pct_book":{"value":0.95,"points":33.25},"rank_top10":{"value":5,"points":15.0},"tilt":{"value":4.252,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"RVMD","issuer":"Revolution Medicines, Inc.","shares":9555357.0,"value_usd":929258468.0,"pct_book":5.34,"position_rank":6,"tilt_pp":4.104,"action":"hold","shares_change_pct":1.1,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":67.8,"tier":"moderate","components":{"pct_book":{"value":0.938,"points":32.81},"rank_top10":{"value":6,"points":15.0},"tilt":{"value":4.104,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"CELC","issuer":"Celcuity Inc.","shares":7915792.0,"value_usd":903508499.0,"pct_book":5.19,"position_rank":7,"tilt_pp":3.957,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":67.4,"tier":"moderate","components":{"pct_book":{"value":0.925,"points":32.38},"rank_top10":{"value":7,"points":15.0},"tilt":{"value":3.957,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"KOD","issuer":"Kodiak Sciences Inc.","shares":19919186.0,"value_usd":759319370.0,"pct_book":4.36,"position_rank":8,"tilt_pp":3.129,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":66.9,"tier":"moderate","components":{"pct_book":{"value":0.912,"points":31.94},"rank_top10":{"value":8,"points":15.0},"tilt":{"value":3.129,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"KYMR","issuer":"Kymera Therapeutics, Inc.","shares":8657242.0,"value_usd":721061686.0,"pct_book":4.14,"position_rank":9,"tilt_pp":2.909,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":66.5,"tier":"moderate","components":{"pct_book":{"value":0.9,"points":31.5},"rank_top10":{"value":9,"points":15.0},"tilt":{"value":2.909,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"SMMT","issuer":"Summit Therapeutics Inc.","shares":36391063.0,"value_usd":689974554.0,"pct_book":3.96,"position_rank":10,"tilt_pp":2.73,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":66.1,"tier":"moderate","components":{"pct_book":{"value":0.887,"points":31.06},"rank_top10":{"value":10,"points":15.0},"tilt":{"value":2.73,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"PRAX","issuer":"Praxis Precision Medicines, Inc.","shares":1753198.0,"value_usd":564862864.0,"pct_book":3.24,"position_rank":11,"tilt_pp":2.012,"action":"add","shares_change_pct":55.6,"add_streak_q":2,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":60.6,"tier":"moderate","components":{"pct_book":{"value":0.875,"points":30.62},"rank_top10":{"value":11,"points":0.0},"tilt":{"value":2.012,"points":10.0},"add_streak":{"value":2,"points":10.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"RYTM","issuer":"Rhythm Pharmaceuticals, Inc.","shares":5604483.0,"value_usd":487421887.0,"pct_book":2.8,"position_rank":12,"tilt_pp":1.567,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":50.2,"tier":"moderate","components":{"pct_book":{"value":0.863,"points":30.19},"rank_top10":{"value":12,"points":0.0},"tilt":{"value":1.567,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ALKS","issuer":"Alkermes plc","shares":10012267.0,"value_usd":354033761.0,"pct_book":2.03,"position_rank":13,"tilt_pp":0.802,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Health Care","themes":[],"since_excess":0.3657,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":49.8,"tier":"moderate","components":{"pct_book":{"value":0.85,"points":29.75},"rank_top10":{"value":13,"points":0.0},"tilt":{"value":0.802,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"GRAL","issuer":"GRAIL, Inc.","shares":4028614.0,"value_usd":208198772.0,"pct_book":1.2,"position_rank":14,"tilt_pp":-0.036,"action":"add","shares_change_pct":93.2,"add_streak_q":2,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":49.3,"tier":"moderate","components":{"pct_book":{"value":0.838,"points":29.31},"rank_top10":{"value":14,"points":0.0},"tilt":{"value":-0.036,"points":0.0},"add_streak":{"value":2,"points":10.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"EWTX","issuer":"Edgewise Therapeutics, Inc.","shares":6575940.0,"value_usd":207142110.0,"pct_book":1.19,"position_rank":15,"tilt_pp":-0.042,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":38.9,"tier":"low","components":{"pct_book":{"value":0.825,"points":28.88},"rank_top10":{"value":15,"points":0.0},"tilt":{"value":-0.042,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"IONS","issuer":"Ionis Pharmaceuticals, Inc.","shares":2047727.0,"value_usd":153763820.0,"pct_book":0.88,"position_rank":16,"tilt_pp":-0.348,"action":"add","shares_change_pct":14.3,"add_streak_q":3,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":53.4,"tier":"moderate","components":{"pct_book":{"value":0.812,"points":28.44},"rank_top10":{"value":16,"points":0.0},"tilt":{"value":-0.348,"points":0.0},"add_streak":{"value":3,"points":15.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"IMVT","issuer":"Immunovant, Inc.","shares":5457881.0,"value_usd":135573764.0,"pct_book":0.78,"position_rank":17,"tilt_pp":-0.453,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":38.0,"tier":"low","components":{"pct_book":{"value":0.8,"points":28.0},"rank_top10":{"value":17,"points":0.0},"tilt":{"value":-0.453,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ROIV","issuer":"Roivant Sciences Ltd.","shares":4867723.0,"value_usd":134835927.0,"pct_book":0.77,"position_rank":18,"tilt_pp":-0.457,"action":"trim","shares_change_pct":-12.4,"add_streak_q":0,"persistence":"persisted","sector":"Health Care","themes":[],"since_excess":0.17,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":37.6,"tier":"low","components":{"pct_book":{"value":0.787,"points":27.56},"rank_top10":{"value":18,"points":0.0},"tilt":{"value":-0.457,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"IDYA","issuer":"IDEAYA Biosciences, Inc.","shares":3946515.0,"value_usd":131497880.0,"pct_book":0.76,"position_rank":19,"tilt_pp":-0.476,"action":"hold","shares_change_pct":9.1,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":37.1,"tier":"low","components":{"pct_book":{"value":0.775,"points":27.12},"rank_top10":{"value":19,"points":0.0},"tilt":{"value":-0.476,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ARWR","issuer":"Arrowhead Pharmaceuticals, Inc.","shares":1992783.0,"value_usd":124947494.0,"pct_book":0.72,"position_rank":20,"tilt_pp":-0.514,"action":"hold","shares_change_pct":-8.4,"add_streak_q":0,"persistence":"persisted","sector":"Health Care","themes":[],"since_excess":-0.0844,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":36.7,"tier":"low","components":{"pct_book":{"value":0.762,"points":26.69},"rank_top10":{"value":20,"points":0.0},"tilt":{"value":-0.514,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"STOK","issuer":"Stoke Therapeutics, Inc.","shares":3336697.0,"value_usd":108642854.0,"pct_book":0.62,"position_rank":21,"tilt_pp":-0.608,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":36.2,"tier":"low","components":{"pct_book":{"value":0.75,"points":26.25},"rank_top10":{"value":21,"points":0.0},"tilt":{"value":-0.608,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ABCL","issuer":"AbCellera Biologics Inc.","shares":30275938.0,"value_usd":105663024.0,"pct_book":0.61,"position_rank":22,"tilt_pp":-0.625,"action":"hold","shares_change_pct":10.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":35.8,"tier":"low","components":{"pct_book":{"value":0.738,"points":25.81},"rank_top10":{"value":22,"points":0.0},"tilt":{"value":-0.625,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ABVX","issuer":"Abivax S.A.","shares":875796.0,"value_usd":97519885.0,"pct_book":0.56,"position_rank":23,"tilt_pp":-0.671,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":35.4,"tier":"low","components":{"pct_book":{"value":0.725,"points":25.38},"rank_top10":{"value":23,"points":0.0},"tilt":{"value":-0.671,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"CRNX","issuer":"Crinetics Pharmaceuticals, Inc.","shares":2351465.0,"value_usd":85405209.0,"pct_book":0.49,"position_rank":24,"tilt_pp":-0.741,"action":"add","shares_change_pct":42.6,"add_streak_q":2,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":44.9,"tier":"low","components":{"pct_book":{"value":0.713,"points":24.94},"rank_top10":{"value":24,"points":0.0},"tilt":{"value":-0.741,"points":0.0},"add_streak":{"value":2,"points":10.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"REPL","issuer":"Replimune Group, Inc.","shares":11045336.0,"value_usd":84496820.0,"pct_book":0.49,"position_rank":25,"tilt_pp":-0.746,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":34.9,"tier":"low","components":{"pct_book":{"value":0.713,"points":24.94},"rank_top10":{"value":25,"points":0.0},"tilt":{"value":-0.746,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"CELC 2.75 08-01-31","issuer":"Celcuity Inc.","shares":30750000.0,"value_usd":74868563.0,"pct_book":0.43,"position_rank":26,"tilt_pp":-0.801,"action":"new","shares_change_pct":null,"add_streak_q":1,"persistence":"pending","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":29.1,"tier":"low","components":{"pct_book":{"value":0.688,"points":24.06},"rank_top10":{"value":26,"points":0.0},"tilt":{"value":-0.801,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"pending","points":0.0}}}},{"ticker":"NRIX","issuer":"Nurix Therapeutics, Inc.","shares":4658556.0,"value_usd":72207618.0,"pct_book":0.41,"position_rank":27,"tilt_pp":-0.817,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":33.6,"tier":"low","components":{"pct_book":{"value":0.675,"points":23.62},"rank_top10":{"value":27,"points":0.0},"tilt":{"value":-0.817,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"DNLI","issuer":"Denali Therapeutics Inc.","shares":3731695.0,"value_usd":71648544.0,"pct_book":0.41,"position_rank":28,"tilt_pp":-0.82,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":33.6,"tier":"low","components":{"pct_book":{"value":0.675,"points":23.62},"rank_top10":{"value":28,"points":0.0},"tilt":{"value":-0.82,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"DNTH","issuer":"Dianthus Therapeutics, Inc.","shares":852164.0,"value_usd":71513603.0,"pct_book":0.41,"position_rank":29,"tilt_pp":-0.821,"action":"hold","shares_change_pct":7.9,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":33.6,"tier":"low","components":{"pct_book":{"value":0.675,"points":23.62},"rank_top10":{"value":29,"points":0.0},"tilt":{"value":-0.821,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"GLUE","issuer":"Monte Rosa Therapeutics, Inc.","shares":4345736.0,"value_usd":71487357.0,"pct_book":0.41,"position_rank":30,"tilt_pp":-0.821,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":33.6,"tier":"low","components":{"pct_book":{"value":0.675,"points":23.62},"rank_top10":{"value":30,"points":0.0},"tilt":{"value":-0.821,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"GPCR","issuer":"Structure Therapeutics Inc.","shares":1432529.0,"value_usd":69047898.0,"pct_book":0.4,"position_rank":31,"tilt_pp":-0.835,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[{"key":"obesity_glp1","name":"GLP-1 & Obesity","name_zh":"GLP-1 \u4e0e\u51cf\u80a5\u836f"}],"since_excess":0.1741,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":31.9,"tier":"low","components":{"pct_book":{"value":0.625,"points":21.88},"rank_top10":{"value":31,"points":0.0},"tilt":{"value":-0.835,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"TRDA","issuer":"Entrada Therapeutics, Inc.","shares":5072730.0,"value_usd":64017853.0,"pct_book":0.37,"position_rank":32,"tilt_pp":-0.864,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":31.4,"tier":"low","components":{"pct_book":{"value":0.613,"points":21.44},"rank_top10":{"value":32,"points":0.0},"tilt":{"value":-0.864,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"BCYC","issuer":"Bicycle Therapeutics plc","shares":10885357.0,"value_usd":50508056.0,"pct_book":0.29,"position_rank":33,"tilt_pp":-0.941,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":31.0,"tier":"low","components":{"pct_book":{"value":0.6,"points":21.0},"rank_top10":{"value":33,"points":0.0},"tilt":{"value":-0.941,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"SYRE","issuer":"Spyre Therapeutics, Inc.","shares":1000000.0,"value_usd":50440000.0,"pct_book":0.29,"position_rank":34,"tilt_pp":-0.942,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":31.0,"tier":"low","components":{"pct_book":{"value":0.6,"points":21.0},"rank_top10":{"value":34,"points":0.0},"tilt":{"value":-0.942,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"RAPP","issuer":"Rapport Therapeutics, Inc.","shares":1547090.0,"value_usd":48408446.0,"pct_book":0.28,"position_rank":35,"tilt_pp":-0.953,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":30.1,"tier":"low","components":{"pct_book":{"value":0.575,"points":20.12},"rank_top10":{"value":35,"points":0.0},"tilt":{"value":-0.953,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ALMS","issuer":"Alumis Inc.","shares":2012500.0,"value_usd":44335375.0,"pct_book":0.25,"position_rank":36,"tilt_pp":-0.977,"action":"add","shares_change_pct":28.8,"add_streak_q":1,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":34.7,"tier":"low","components":{"pct_book":{"value":0.562,"points":19.69},"rank_top10":{"value":36,"points":0.0},"tilt":{"value":-0.977,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"MIRM","issuer":"Mirum Pharmaceuticals, Inc.","shares":445975.0,"value_usd":41199171.0,"pct_book":0.24,"position_rank":37,"tilt_pp":-0.995,"action":"new","shares_change_pct":null,"add_streak_q":1,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":34.2,"tier":"low","components":{"pct_book":{"value":0.55,"points":19.25},"rank_top10":{"value":37,"points":0.0},"tilt":{"value":-0.995,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"VRDN","issuer":"Viridian Therapeutics, Inc.","shares":1971678.0,"value_usd":38566022.0,"pct_book":0.22,"position_rank":38,"tilt_pp":-1.01,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":28.8,"tier":"low","components":{"pct_book":{"value":0.537,"points":18.81},"rank_top10":{"value":38,"points":0.0},"tilt":{"value":-1.01,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ELVN","issuer":"Enliven Therapeutics, Inc.","shares":905191.0,"value_usd":35483487.0,"pct_book":0.2,"position_rank":39,"tilt_pp":-1.028,"action":"add","shares_change_pct":233.5,"add_streak_q":2,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":38.4,"tier":"low","components":{"pct_book":{"value":0.525,"points":18.38},"rank_top10":{"value":39,"points":0.0},"tilt":{"value":-1.028,"points":0.0},"add_streak":{"value":2,"points":10.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"PRLD","issuer":"Prelude Therapeutics Inc.","shares":10123824.0,"value_usd":34623478.0,"pct_book":0.2,"position_rank":40,"tilt_pp":-1.033,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":28.4,"tier":"low","components":{"pct_book":{"value":0.525,"points":18.38},"rank_top10":{"value":40,"points":0.0},"tilt":{"value":-1.033,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"DBVT","issuer":"DBV Technologies S.A.","shares":1461425.0,"value_usd":30529168.0,"pct_book":0.18,"position_rank":41,"tilt_pp":-1.056,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":27.5,"tier":"low","components":{"pct_book":{"value":0.5,"points":17.5},"rank_top10":{"value":41,"points":0.0},"tilt":{"value":-1.056,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"DSGN","issuer":"Design Therapeutics, Inc.","shares":2585978.0,"value_usd":27514806.0,"pct_book":0.16,"position_rank":42,"tilt_pp":-1.073,"action":"add","shares_change_pct":15.8,"add_streak_q":2,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":37.1,"tier":"low","components":{"pct_book":{"value":0.487,"points":17.06},"rank_top10":{"value":42,"points":0.0},"tilt":{"value":-1.073,"points":0.0},"add_streak":{"value":2,"points":10.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"260","issuer":"Centessa Pharmaceuticals plc","shares":670751.0,"value_usd":26642230.0,"pct_book":0.15,"position_rank":43,"tilt_pp":-1.078,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":26.6,"tier":"low","components":{"pct_book":{"value":0.475,"points":16.62},"rank_top10":{"value":43,"points":0.0},"tilt":{"value":-1.078,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"CTMX","issuer":"CytomX Therapeutics, Inc.","shares":4975826.0,"value_usd":23386382.0,"pct_book":0.13,"position_rank":44,"tilt_pp":-1.097,"action":"add","shares_change_pct":17.1,"add_streak_q":1,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":31.2,"tier":"low","components":{"pct_book":{"value":0.463,"points":16.19},"rank_top10":{"value":44,"points":0.0},"tilt":{"value":-1.097,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"JBIO","issuer":"Jade Biosciences, Inc.","shares":1641137.0,"value_usd":23057975.0,"pct_book":0.13,"position_rank":45,"tilt_pp":-1.099,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":26.2,"tier":"low","components":{"pct_book":{"value":0.463,"points":16.19},"rank_top10":{"value":45,"points":0.0},"tilt":{"value":-1.099,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"IRON","issuer":"Disc Medicine, Inc.","shares":349657.0,"value_usd":22357069.0,"pct_book":0.13,"position_rank":46,"tilt_pp":-1.103,"action":"hold","shares_change_pct":3.7,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":26.2,"tier":"low","components":{"pct_book":{"value":0.463,"points":16.19},"rank_top10":{"value":46,"points":0.0},"tilt":{"value":-1.103,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"IMCR","issuer":"Immunocore Holdings plc","shares":734397.0,"value_usd":22142070.0,"pct_book":0.13,"position_rank":47,"tilt_pp":-1.104,"action":"trim","shares_change_pct":-68.4,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":26.2,"tier":"low","components":{"pct_book":{"value":0.463,"points":16.19},"rank_top10":{"value":47,"points":0.0},"tilt":{"value":-1.104,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"XENE","issuer":"Xenon Pharmaceuticals Inc.","shares":370208.0,"value_usd":21527595.0,"pct_book":0.12,"position_rank":48,"tilt_pp":-1.108,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":24.4,"tier":"low","components":{"pct_book":{"value":0.412,"points":14.44},"rank_top10":{"value":48,"points":0.0},"tilt":{"value":-1.108,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"CLDX","issuer":"Celldex Therapeutics, Inc.","shares":665370.0,"value_usd":21105536.0,"pct_book":0.12,"position_rank":49,"tilt_pp":-1.11,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":24.4,"tier":"low","components":{"pct_book":{"value":0.412,"points":14.44},"rank_top10":{"value":49,"points":0.0},"tilt":{"value":-1.11,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"NGNE","issuer":"Neurogene Inc.","shares":991691.0,"value_usd":19992491.0,"pct_book":0.11,"position_rank":50,"tilt_pp":-1.117,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":23.6,"tier":"low","components":{"pct_book":{"value":0.388,"points":13.56},"rank_top10":{"value":50,"points":0.0},"tilt":{"value":-1.117,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"EVMN","issuer":"Evommune, Inc.","shares":847390.0,"value_usd":19481496.0,"pct_book":0.11,"position_rank":51,"tilt_pp":-1.119,"action":"new","shares_change_pct":null,"add_streak_q":1,"persistence":"pending","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":18.6,"tier":"low","components":{"pct_book":{"value":0.388,"points":13.56},"rank_top10":{"value":51,"points":0.0},"tilt":{"value":-1.119,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"pending","points":0.0}}}},{"ticker":"TECX","issuer":"Tectonic Therapeutic, Inc.","shares":607788.0,"value_usd":18786727.0,"pct_book":0.11,"position_rank":52,"tilt_pp":-1.123,"action":"trim","shares_change_pct":-32.7,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":23.6,"tier":"low","components":{"pct_book":{"value":0.388,"points":13.56},"rank_top10":{"value":52,"points":0.0},"tilt":{"value":-1.123,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"CTNM","issuer":"Contineum Therapeutics, Inc.","shares":1420838.0,"value_usd":18556144.0,"pct_book":0.11,"position_rank":53,"tilt_pp":-1.125,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":23.6,"tier":"low","components":{"pct_book":{"value":0.388,"points":13.56},"rank_top10":{"value":53,"points":0.0},"tilt":{"value":-1.125,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ARGX","issuer":"argenx SE","shares":25174.0,"value_usd":18383314.0,"pct_book":0.11,"position_rank":54,"tilt_pp":-1.126,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":23.6,"tier":"low","components":{"pct_book":{"value":0.388,"points":13.56},"rank_top10":{"value":54,"points":0.0},"tilt":{"value":-1.126,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"CERS","issuer":"Cerus Corporation","shares":10008345.0,"value_usd":18215188.0,"pct_book":0.1,"position_rank":55,"tilt_pp":-1.127,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":21.4,"tier":"low","components":{"pct_book":{"value":0.325,"points":11.38},"rank_top10":{"value":55,"points":0.0},"tilt":{"value":-1.127,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"TSHA","issuer":"Taysha Gene Therapies, Inc.","shares":4004756.0,"value_usd":17901259.0,"pct_book":0.1,"position_rank":56,"tilt_pp":-1.129,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":21.4,"tier":"low","components":{"pct_book":{"value":0.325,"points":11.38},"rank_top10":{"value":56,"points":0.0},"tilt":{"value":-1.129,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"AKTS","issuer":"Aktis Oncology, Inc.","shares":996351.0,"value_usd":17824719.0,"pct_book":0.1,"position_rank":57,"tilt_pp":-1.129,"action":"new","shares_change_pct":null,"add_streak_q":1,"persistence":"pending","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":16.4,"tier":"low","components":{"pct_book":{"value":0.325,"points":11.38},"rank_top10":{"value":57,"points":0.0},"tilt":{"value":-1.129,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"pending","points":0.0}}}},{"ticker":"GENB","issuer":"Generate Biomedicines, Inc.","shares":1423602.0,"value_usd":17795025.0,"pct_book":0.1,"position_rank":58,"tilt_pp":-1.129,"action":"new","shares_change_pct":null,"add_streak_q":1,"persistence":"pending","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":16.4,"tier":"low","components":{"pct_book":{"value":0.325,"points":11.38},"rank_top10":{"value":58,"points":0.0},"tilt":{"value":-1.129,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"pending","points":0.0}}}},{"ticker":"SION","issuer":"Sionna Therapeutics, Inc.","shares":400000.0,"value_usd":16036000.0,"pct_book":0.09,"position_rank":59,"tilt_pp":-1.139,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":19.6,"tier":"low","components":{"pct_book":{"value":0.275,"points":9.62},"rank_top10":{"value":59,"points":0.0},"tilt":{"value":-1.139,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"DYN","issuer":"Dyne Therapeutics, Inc.","shares":813449.0,"value_usd":14747830.0,"pct_book":0.08,"position_rank":60,"tilt_pp":-1.147,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":19.2,"tier":"low","components":{"pct_book":{"value":0.263,"points":9.19},"rank_top10":{"value":60,"points":0.0},"tilt":{"value":-1.147,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"XNCR","issuer":"Xencor, Inc.","shares":1102106.0,"value_usd":13291398.0,"pct_book":0.08,"position_rank":61,"tilt_pp":-1.155,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Health Care","themes":[],"since_excess":0.314,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":19.2,"tier":"low","components":{"pct_book":{"value":0.263,"points":9.19},"rank_top10":{"value":61,"points":0.0},"tilt":{"value":-1.155,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"CMPS","issuer":"COMPASS Pathways plc","shares":2344720.0,"value_usd":12966302.0,"pct_book":0.07,"position_rank":62,"tilt_pp":-1.157,"action":"new","shares_change_pct":null,"add_streak_q":1,"persistence":"pending","sector":null,"themes":[{"key":"fv:healthcaretherapeutics","name":"Therapeutics","name_zh":"Therapeutics"}],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":13.3,"tier":"low","components":{"pct_book":{"value":0.237,"points":8.31},"rank_top10":{"value":62,"points":0.0},"tilt":{"value":-1.157,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"pending","points":0.0}}}},{"ticker":"RLAY","issuer":"Relay Therapeutics, Inc.","shares":1160117.0,"value_usd":11543164.0,"pct_book":0.07,"position_rank":63,"tilt_pp":-1.165,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":18.3,"tier":"low","components":{"pct_book":{"value":0.237,"points":8.31},"rank_top10":{"value":63,"points":0.0},"tilt":{"value":-1.165,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"SERA","issuer":"Sera Prognostics, Inc.","shares":5498170.0,"value_usd":11161285.0,"pct_book":0.06,"position_rank":64,"tilt_pp":-1.167,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":17.4,"tier":"low","components":{"pct_book":{"value":0.212,"points":7.44},"rank_top10":{"value":64,"points":0.0},"tilt":{"value":-1.167,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"BNTX","issuer":"BioNTech SE","shares":119743.0,"value_usd":10642758.0,"pct_book":0.06,"position_rank":65,"tilt_pp":-1.17,"action":"trim","shares_change_pct":-67.5,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[{"key":"fv:healthcarenextgen","name":"Next-Gen","name_zh":"Next-Gen"},{"key":"fv:healthcareoncology","name":"Oncology","name_zh":"Oncology"}],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":17.4,"tier":"low","components":{"pct_book":{"value":0.212,"points":7.44},"rank_top10":{"value":65,"points":0.0},"tilt":{"value":-1.17,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"RCUS","issuer":"Arcus Biosciences, Inc.","shares":415621.0,"value_usd":8977414.0,"pct_book":0.05,"position_rank":66,"tilt_pp":-1.18,"action":"add","shares_change_pct":53.9,"add_streak_q":2,"persistence":"persisted","sector":"Health Care","themes":[],"since_excess":0.1571,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":26.6,"tier":"low","components":{"pct_book":{"value":0.188,"points":6.56},"rank_top10":{"value":66,"points":0.0},"tilt":{"value":-1.18,"points":0.0},"add_streak":{"value":2,"points":10.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"MPLT","issuer":"MapLight Therapeutics, Inc.","shares":364705.0,"value_usd":7414453.0,"pct_book":0.04,"position_rank":67,"tilt_pp":-1.189,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":16.1,"tier":"low","components":{"pct_book":{"value":0.175,"points":6.12},"rank_top10":{"value":67,"points":0.0},"tilt":{"value":-1.189,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ABSI","issuer":"Absci Corporation","shares":2134803.0,"value_usd":6404409.0,"pct_book":0.04,"position_rank":68,"tilt_pp":-1.195,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":16.1,"tier":"low","components":{"pct_book":{"value":0.175,"points":6.12},"rank_top10":{"value":68,"points":0.0},"tilt":{"value":-1.195,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"VTVT","issuer":"vTv Therapeutics, Inc.","shares":148314.0,"value_usd":5882133.0,"pct_book":0.03,"position_rank":69,"tilt_pp":-1.198,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":15.2,"tier":"low","components":{"pct_book":{"value":0.15,"points":5.25},"rank_top10":{"value":69,"points":0.0},"tilt":{"value":-1.198,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"EIKN","issuer":"Eikon Therapeutics, Inc.","shares":555555.0,"value_usd":5877772.0,"pct_book":0.03,"position_rank":70,"tilt_pp":-1.198,"action":"new","shares_change_pct":null,"add_streak_q":1,"persistence":"pending","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":10.2,"tier":"low","components":{"pct_book":{"value":0.15,"points":5.25},"rank_top10":{"value":70,"points":0.0},"tilt":{"value":-1.198,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"pending","points":0.0}}}},{"ticker":"TARA","issuer":"Protara Therapeutics, Inc.","shares":971614.0,"value_usd":5062109.0,"pct_book":0.03,"position_rank":71,"tilt_pp":-1.202,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":15.2,"tier":"low","components":{"pct_book":{"value":0.15,"points":5.25},"rank_top10":{"value":71,"points":0.0},"tilt":{"value":-1.202,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"SGMT","issuer":"Sagimet Biosciences Inc.","shares":952996.0,"value_usd":4979404.0,"pct_book":0.03,"position_rank":72,"tilt_pp":-1.203,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":15.2,"tier":"low","components":{"pct_book":{"value":0.15,"points":5.25},"rank_top10":{"value":72,"points":0.0},"tilt":{"value":-1.203,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"LBRX","issuer":"LB Pharmaceuticals Inc.","shares":200000.0,"value_usd":4932000.0,"pct_book":0.03,"position_rank":73,"tilt_pp":-1.203,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":15.2,"tier":"low","components":{"pct_book":{"value":0.15,"points":5.25},"rank_top10":{"value":73,"points":0.0},"tilt":{"value":-1.203,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"VSTM","issuer":"Verastem, Inc.","shares":584757.0,"value_usd":3099212.0,"pct_book":0.02,"position_rank":74,"tilt_pp":-1.214,"action":"new","shares_change_pct":null,"add_streak_q":1,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":18.1,"tier":"low","components":{"pct_book":{"value":0.087,"points":3.06},"rank_top10":{"value":74,"points":0.0},"tilt":{"value":-1.214,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"TCRX","issuer":"TScan Therapeutics, Inc.","shares":2784792.0,"value_usd":2812640.0,"pct_book":0.02,"position_rank":75,"tilt_pp":-1.215,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":13.1,"tier":"low","components":{"pct_book":{"value":0.087,"points":3.06},"rank_top10":{"value":75,"points":0.0},"tilt":{"value":-1.215,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"SKYE","issuer":"Skye Bioscience, Inc.","shares":1575243.0,"value_usd":968144.0,"pct_book":0.01,"position_rank":76,"tilt_pp":-1.226,"action":"hold","shares_change_pct":8.6,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":12.2,"tier":"low","components":{"pct_book":{"value":0.062,"points":2.19},"rank_top10":{"value":76,"points":0.0},"tilt":{"value":-1.226,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"SANA","issuer":"Sana Biotechnology, Inc.","shares":310483.0,"value_usd":894191.0,"pct_book":0.01,"position_rank":77,"tilt_pp":-1.226,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[{"key":"fv:healthcaretherapeutics","name":"Therapeutics","name_zh":"Therapeutics"}],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":12.2,"tier":"low","components":{"pct_book":{"value":0.062,"points":2.19},"rank_top10":{"value":77,"points":0.0},"tilt":{"value":-1.226,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ALGS","issuer":"Aligos Therapeutics, Inc.","shares":83055.0,"value_usd":617099.0,"pct_book":0.0,"position_rank":78,"tilt_pp":-1.228,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":11.3,"tier":"low","components":{"pct_book":{"value":0.037,"points":1.31},"rank_top10":{"value":78,"points":0.0},"tilt":{"value":-1.228,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"TYRA","issuer":"Tyra Biosciences, Inc.","shares":10607.0,"value_usd":406248.0,"pct_book":0.0,"position_rank":79,"tilt_pp":-1.229,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":11.3,"tier":"low","components":{"pct_book":{"value":0.037,"points":1.31},"rank_top10":{"value":79,"points":0.0},"tilt":{"value":-1.229,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"SRZNW","issuer":"Surrozen, Inc.","shares":833333.0,"value_usd":13333.0,"pct_book":0.0,"position_rank":80,"tilt_pp":-1.231,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":11.3,"tier":"low","components":{"pct_book":{"value":0.037,"points":1.31},"rank_top10":{"value":80,"points":0.0},"tilt":{"value":-1.231,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}}],"book_meta":{"n_positions":84,"n_resolved":80,"resolution_pct":95.2,"book_value_usd":17415689929.0,"filing_date":"2026-05-15","period_end":"2026-03-31"},"sector_series":[{"period_end":"2023-03-31","filing_date":"2023-05-15","weights":{"Unclassified":79.12,"Healthcare":14.22,"Health Care":6.65},"top_theme_weights":{"US Sectors (EW)":14.22}},{"period_end":"2023-06-30","filing_date":"2023-08-14","weights":{"Unclassified":78.26,"Healthcare":13.14,"Health Care":8.6},"top_theme_weights":{"US Sectors (EW)":13.14}},{"period_end":"2023-09-30","filing_date":"2023-11-14","weights":{"Unclassified":79.78,"Healthcare":12.14,"Health Care":8.08},"top_theme_weights":{"US Sectors (EW)":12.14}},{"period_end":"2023-12-31","filing_date":"2024-02-14","weights":{"Unclassified":56.93,"Healthcare":26.27,"Health Care":16.8},"top_theme_weights":{"US Sectors (EW)":26.26,"Healthcare":0.01}},{"period_end":"2024-03-31","filing_date":"2024-05-15","weights":{"Unclassified":62.68,"Healthcare":25.87,"Health Care":11.45},"top_theme_weights":{"US Sectors (EW)":25.86,"Healthcare":0.01}},{"period_end":"2024-06-30","filing_date":"2024-08-14","weights":{"Unclassified":64.41,"Healthcare":24.28,"Health Care":11.31},"top_theme_weights":{"US Sectors (EW)":24.27,"Healthcare":0.01}},{"period_end":"2024-09-30","filing_date":"2024-11-14","weights":{"Unclassified":69.78,"Healthcare":21.29,"Health Care":8.93},"top_theme_weights":{"US Sectors (EW)":21.27,"Healthcare":0.05}},{"period_end":"2024-12-31","filing_date":"2025-02-14","weights":{"Unclassified":66.17,"Healthcare":22.98,"Health Care":10.85},"top_theme_weights":{"US Sectors (EW)":22.98,"Healthcare":0.11}},{"period_end":"2025-03-31","filing_date":"2025-05-15","weights":{"Unclassified":69.0,"Healthcare":20.83,"Health Care":10.17},"top_theme_weights":{"US Sectors (EW)":20.83,"Healthcare":0.07}},{"period_end":"2025-06-30","filing_date":"2025-08-14","weights":{"Unclassified":68.3,"Healthcare":20.31,"Health Care":11.39},"top_theme_weights":{"US Sectors (EW)":20.31,"Healthcare":0.5}},{"period_end":"2025-09-30","filing_date":"2025-11-14","weights":{"Unclassified":71.76,"Healthcare":18.9,"Health Care":9.34},"top_theme_weights":{"US Sectors (EW)":18.9,"Healthcare":0.39}},{"period_end":"2025-12-31","filing_date":"2026-02-17","weights":{"Unclassified":72.05,"Healthcare":17.85,"Health Care":10.1},"top_theme_weights":{"US Sectors (EW)":17.85,"Healthcare":0.59}},{"period_end":"2026-03-31","filing_date":"2026-05-15","weights":{"Unclassified":74.25,"Healthcare":16.62,"Health Care":9.14},"top_theme_weights":{"US Sectors (EW)":16.62,"Healthcare":0.4}}],"sector_rotation":{"into":[],"out_of":[{"sector":"Healthcare","delta_pp":-1.23},{"sector":"Health Care","delta_pp":-0.96}],"deltas":{"Unclassified":2.2,"Health Care":-0.96,"Healthcare":-1.23},"period_end":"2026-03-31","prev_period_end":"2025-12-31","method_note":{"en":"Current sector/theme map applied to history \u2014 historical quarters are classified with today's sector and theme membership (survivorship-lite; past classification changes are not reconstructed).","zh":"\u4ee5\u5f53\u524d\u884c\u4e1a/\u4e3b\u9898\u6620\u5c04\u56de\u6eaf\u5386\u53f2\u2014\u2014\u5386\u53f2\u5b63\u5ea6\u6309\u4eca\u65e5\u7684\u884c\u4e1a\u4e0e\u4e3b\u9898\u6210\u5458\u5206\u7c7b\uff08\u8f7b\u5ea6\u5e78\u5b58\u8005\u53e3\u5f84\uff1b\u4e0d\u91cd\u5efa\u8fc7\u53bb\u7684\u5206\u7c7b\u53d8\u66f4\uff09\u3002"}},"theme_read":{"leans":[{"theme_key":"fv:healthcaretherapeutics","label":"Therapeutics","label_zh":"Therapeutics","category":"Healthcare & Biotech","source":"finviz","tickers":["CMPS"],"added_pp":0.07,"held_pp":0.08,"n_names":2}],"core":{"theme_key":"fv:healthcaretherapeutics","label":"Therapeutics","label_zh":"Therapeutics","category":"Healthcare & Biotech","source":"finviz","tickers":["CMPS"],"added_pp":0.07,"held_pp":0.08,"n_names":2},"narrative_en":"Core lean: Therapeutics \u2014 added CMPS (+0.1pp of book this quarter)","narrative_zh":"\u6838\u5fc3\u503e\u5411\uff1aTherapeutics \u2014 \u672c\u5b63\u5ea6\u52a0\u4ed3 CMPS\uff08\u5360\u7ec4\u5408 +0.1pp\uff09"}}